Abstract. The intracellular flow and fate of two fluorescently labeled sphingolipids, 6-[N-(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]hexanoyl glucosyl sphingosine (C6-NBD-glucosylceramide) and C6-NBDsphingomyelin, was examined in the human colon adenocarcinoma cell line HT29. After their insertion into the plasma membrane at low temperature and subsequent warming of the cells to 37°C, both sphingolipid analogues were internalized by endocytosis, but their intracellular site of destination differed. After 30 min of internalization, C6-NBD-glucosylceramide was localized in the Golgi apparatus, as demonstrated by colocalization with fluorescently labeled ceramide, a Golgi complex marker, and by showing that monensininduced disruption of the Golgi structure was paralleled by a similar perturbation of the fluorescence distribution. By contrast, C6-NBD-sphingomyelin does
not colocalize with the tagged ceramide. Rather, a colocalization with ricin, which is internalized by endocytosis and predominantly reaches the lysosomes, was observed, indicating that the site of delivery of this lipid is restricted to endosomal/lysosomal compartments . Also, in monensin-treated cells no change in the distribution of fluorescence was observed. Thus, these results demonstrate that (sphingo)lipid sorting can occur in the endocytic pathway. Interestingly, the observed sorting phenomenon was specific for glucosylceramide, when compared to other glycolipids, while only undifferentiated HT29 cells displayed the different routing of the two lipids . In differentiated HT29 cells the internalization pathway of sphingomyelin and glucosylceramide was indistinguishable from that of transferrin .
beled sphingolipids, C6-NBD-glucosylceramide and C6-NBD-sphingomyelin, are sorted during internalization along the endocytic pathway in HT29 cells . Using transferrin (Tf)l and ricin (in conjunction with their receptors) as intracellular traffic markers, evidence is presented indicating that C6-NBD-glucosylceramide is transported to the Golgi apparatus, whereas C6-NBD-sphingomyelin follows the endocytic pathway, down to the endosomal/lysosomal system . Furthermore, when the trafficking ofthese sphingolipids was compared in an undifferentiated and a differentiated HT29 cell type, the latter being derived by clonal selection, it could be shown that this sorting phenomenon only occurred in the undifferentiated cell type. This distinct difference between the two cell types may imply that lipid transport routes and sorting phenomena are related to differentiation of cells . . Intracellular localization of sphingolipids in undifferentiated HT29 cells. Cells were labeled with 4 UM C6-NBDglucosylceramide (a and c), C6-NBD-galactosylceramide (e), or C6-NBD-sphingomyelin (g and i), as described in Materials and Methods. Internalization was allowed to proceed for 30 min at 37°C, followed by a back-exchange procedure at 2°C. Colabeling studies were performed with either DECA-ceramide (b and h) or LR-ricin (d, f, and j) as described in Materials and Methods. Note that C6-NBD-glucosylceramide colocalizes with DECA-ceramide (a and b), but not with LR-ricin (c and d) . C6-NBD-sphingomyelin colocalizes with LR-ricin (i and j), but not with DECA-ceramide (g and h) . Bars, 10 um . Synthesis of C6-NBD-labeled Sphingolipids C6-NBD-glucosylceramide, C6-NBD-galactosylceramide, C6-NBD-lactosylceramide, C6-NBD-sphingomyelin, and C6-NBD-ceramide were synthesized from C6-NBD and 1o-D-glucosylsphingosine, 1-ß-D-galactosylsphingosine, 1-ß-DL-lactosyldihydrosphingosine, sphingosylphosphorylcholine, and D-sphingosine, respectively, as described (4) . 1-ß-D-galactosylsphingosine and 1-ß-13L-lactosyldihydrosphingosine were prepared (3) from cerebroside (type II) and N-pahnitcyl-DL-dihydrolactocerebroside, respectively. The C6-NBD-lipids were quantitated spectrophotometrically in a fluorometer (model MPF-43 ; Perkin-Elmer Corp., Norwalk, CT) with an excitation wavelength of 465 nm and an emission wavelength of 530 nm, by reference to known amounts of C6-NBD-phosphatidylcholine.
Materials and Methods

Protein Labeling
Saturation of Tf with iron was carried out by the procedure of Van Renswoude et al . (15) . Diferric Tf and ricin were conjugated with LR as described elsewhere (5) .
Cell Culture and Membrane Insertion of Fluorescent Lipids
Monolayer cultures of HT29 cells were grown in DME, supplemented with 10% (vol/vol) FCS in a water-saturated atmosphere of 5% COZ/95% air.
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Experiments were carried out 24-48 h after passage . C6-NBD-lipid insertion was carried out at 2°C . Before labeling, the cells were cooled to 2°C (30 min) . Appropriate amounts of C6-NBD-lipid, stored in chloroform/methanol (2 :1 [vol/vol]), were dried under nitrogen, and subsequently solubilized in absolute ethanol . An aliquot of the ethanolic solution (0.5% final concentration) was injected into Hank's solution (pH 7.4) under vigorous vortex mixing . This solution was then added to the cells . Alternatively, several microscopy experiments were carried out using C6-NBD-lipid containing liposomes for labeling, as described elsewhere (5) . Both procedures used for labeling yielded identical results .
Back-Exchangefor Membrane-inserted Lipid Analogues
Back-exchange was carried out by incubating the cells for 30 min at 2°C with 5 % (wt/vol) BSA in Hank's solution, followed by extensive washing with Hank's solution. This procedure was repeated twice .
Metabolic Studies
Procedures used for carrying out metabolic studies were analogous to those described below for the microscopy experiments, allowing direct correlation of the results . After the 37°C incubation (and extensive washing), a back-exchange procedure was carried out at 2°C, in order to separate the plasma membrane NBD-lipid fraction from the intracellular pool . Both fractions were analyzed as described below.
Lipid Extraction, Analysis, and Quantification Lipids were extracted by the procedure of Bligh and Dyer and analyzed by two-dimensional TLC on silica gel 60 HPTLC plates (Merck & Co ., Rah-way, NJ), using CHC13/CH30H/20% (wt/vol) NH40H [70 :30 :5] as the running solvent system in the first dimension and CHC13/CH30H/86% (vol/vol) HAc [90:40 :14] in the second dimension, allowing separation of five different C6-NBD-lipid spots associated with HT29 cells . To positively identify C6-NBD-galactosylceramide as one of the C6-NBD-lipids synthesized from C6-NBD-ceramide in HT29 cells, the TLC-system as described by Van Meer et al . (14) was employed . For quantification, individual spots were scraped from the plates and after addition of 3 ml of a 1 % (vol/vol) Triton X-100 solution, shaken vigorously for 1 h at 37°C. After spinning down the silica particles, the supernatant was measured by reference to a standard curve, as described above. Corrections were made for differences in efficiency of removal of different types of lipids from the silica. Data are expressed as the means (t SEM) of triplicate measurements .
Microscopy
Cells were grown on glass coverslips in 35-mm Petri dishes. Before experiments, the cells were cooled (30 min) and washed several times with icecold Hank's solution. For colabeling studies with fluorescently labeled ncm, the cells were labeled with LR-ricin (15 pg/ml) for 30 min at 2°C . Internalization of membrane-bound ricin (after washing away free ricin) was initiated by adding warm Hank's solution (37°C) and allowed to proceed for 60 min . Thereafter, the cells were again cooled to 2°C, followed by labeling with the C6-NBD-lipid for 30 min at 2°C . After washing, internalization was started again by adding warm Hank's solution and terminated after 30 min by replacing warm buffer with ice-cold one . Finally, a back-exchange procedure was done at 2°C, followed by a 0.1 M lactose wash (30 min at 2°C) to remove cell surface-bound ricin .
For colabeling studies with fluorescently labeled Tf, the cells were first labeled with the C6-NBD-lipid for 30 min at 2°C, followed by washing with Hank's solution and subsequent labeling with LR-Tf (0.2 mg/ml) . Internalization was allowed to proceed for 30 min, after which a back-exchange procedure was performed at 2°C . Colabeling studies with DECA-ceramide were done as described above for LR-Tf, except that the cells were first labeled with DECA-ceramide (1 AM), as described for the C6-NBD-lipids, followed by labeling with the C6-NBD-lipid . The labeling concentration of the C6-NBD-lipids was 4 AM .
Monensin experiments were performed by preincubating the cells with the drug (10 -s M) for 30 min at 2°C . Thereafter, the cells were labeled with the C6-NBD-lipid followed by internalization and back-exchange . Throughout these experimental treatments the drug was present. Metabolic inhibition experiments were performed as described (10) . Briefly, cells were preincubated at room temperature for 5 min with 5 mM azide/50 MM 2-deoxyglucose, followed by NBD-sphingolipid labeling at 2°C and subsequent warming of the cells to 37°C in the presence of the drugs. Acidification of the cytosol was achieved by incubating the cells for 30 min at 2°C with 5 AM nigericin in an isotonic KCl buffer solution (140 mM KC1, 2 mM CaC12, 1 rr1M MgC12, 0.5 MM KH2PO4, 20 mM Hepes, pH 5.5) . All subsequent washings and incubations were carried out with the same nigericincontaining buffer solution . After experimental manipulation, the glass coverslips were removed from the Petri dishes and mounted for microscopy.
Fluorescence microscopy was performed with a Leitz Orthoplan microscope equipped with a Leitz Vario Orthomat 2 photography system, and the following filter sets: purple excitation, BP 340-410/LP 470 (DECA channel) ; blue excitation, BP 450-490/LP 515 (NBD-channel) ; and green excitation, BP 530-560/LP 580 (Rh-channel) . Photomicrographs were taken at 10-30-s exposure times using Kodak Tmax P3200 film that was processed at 12 .800 ASA .
Results and Discussion
C6-NW-Sphingolipid Metabolism in H729 Cells
When HT29 cells are incubated with C6-NBD-ceramide, either at 2°C or 37°C, the lipid is taken up into the cells and at 37°C accumulates in the Golgi apparatus where several NBD-sphingohpids are synthesized . Similar observations have been described for other cell types (7, 14) . The two main lipid products synthesized are C6-NBD-glucosylceramide and C6-NBD-sphingomyelin . However, the cells also synthesize C 6-NBD-galactosylceramide, C6-NBD-lactosylceramide, and a third, as yet unidentified C6 -NBD-sphingolipid (Babia, T., J. W Kok, and D. Hoekstra, manuscript in preparation) . Further support for the Golgi localization of C6-NBDglucosylceramide comes from experiments in which monensin was used as a reagent that can disrupt the structural organization ofthe Golgi complex . As a result ofsuch a treatment (Fig. 2) , the Golgi complex in HT29 cells, normally visualized as large, irregularly shaped vesicles that are distinctly located around the nucleus, becomes vesiculated and more spread over the cell . As shown in Fig . 2 , in comparison to its distribution in nontreated cells (Fig . 1) , the distribution of C6 -NBD-glucosylceramide is similarly disrupted in the presence of monensin. In contrast to C6-NBD-glucosylceramide, internalized C6-NBD-sphingomyelin did not colocalize with DECAceramide, implying that sphingomyelin is not transported to the Golgi apparatus. Instead, it was found in an intracellular compartment that can be labeled by LRricin which is taken up into the cells by endocytosis . This result thus indicates that this lipid is transported and confined to the endosomal/lysosomal system . Entirely consistent with this notion was the observation that the labeling pattern of NBDsphingomyelin was not changed after a treatment with monensin that causes disruption of the Golgi (Fig. 2) .
Back-exchange experiments revealed that after 30 min at 37°C -10-15% of the initial membrane-inserted lipid fraction is located intracellularly. The internalization of both lipids is temperature dependent and can be inhibited in the presence of metabolic inhibitors (5 mM azide/50 mM 2-deoxyglucose) (Fig . 3) or when the intracellular pH is lowered to 5.5 with the aid of nigericin (not shown) . Therefore, internalization is energy dependent and accomplished by endocytosis (2, 10). It is highly relevant to note here that on the time scale of the experiments no appreciable breakdown of the C6-NBD-sphingolipids had taken place, as revealed by lipid analyses . The relevance of this notion stems from the fact that the observed labeling ofthe Golgi complex by glucosylceramide might (in part) have been the result of initial lysosomal degradation of glucosylceramide to ceramide, followed by transfer and accumulation ofthis degradation product in the Golgi compartment (8, 9) . The ceramide, in turn, could then have been reutilized (6, 9) for synthesis of glucosylceramide (and sphingomyelin, see below) . However, this possibility can be ruled out . Analysis ofthe intracellular pool of NBD-lipid revealed that after an incubation period of 30 min at 37°C, 91 .3 % (t 1.4%) ofthe intracellular fraction was still present as C6-NBD-glucosylceramide . Furthermore, 6.9% (t 0.9%) was identified as C6-NBD-ceramide, 234 Figure 2 . Effect of monensin on NBD-sphingolipid fluorescence distribution . (a and b) Cells were first labeled with DECA-ceramide (1 AM), followed by labeling with NBD-ceramide (4 AM) . Thereafter, the cells were incubated at 37°C for 30 min. Both NBD-ceramide (a) and DECA-ceramide (b) accumulate in the Golgi-apparatus and thus show the same fluorescence distribution . (c-e) Cells were labeled with 4 AM C6-NBD-ceramide (c), C6-NBD glucosylceramide (d), or C6-NBD-sphingomyelin (e) as described in Materials and Methods. Subsequently, the cells were preincubated for 30 min at 2°C with 10 AM monensin, followed by an incubation at 37°C for 30 min in the presence of the drug. Finally, a back-exchange procedure was carried out. Note the similarity in fluorescence distribution between NBDceramide (c) and NBD-glucosylceramide (d) in monensin-treated cells, and the difference with control cells (a and Fig. 1, a and c, respec- tively). There is no effect on NBD-sphingomyelin fluorescence distribution (e compared to Fig. 1, g and t) . Bar, 10 Am . Kok whereas only 1 .9% (t 1 .1%) of the intracellular NBD-lipid fraction has been reused for synthesis to C6-NBD-sphingomyelin . It should also be noted that the lipid present in the plasma membrane consisted exclusively (99 .6 t 0.3%) of C6 -NBD-glucosylceramide (as determined by analysis of the back-exchanged lipid fraction) . When the sphingolipid precursor, C6-NBD-ceramide, was supplied to the cells for a similar incubation period (30 min at 37°C), both glucosylceramide and sphingomyelin were synthesized (as noted above), while the ratio of glucosylceramide to sphingomyelin in which they were produced is 1 .3 (t 0.1) .
Taken together, it can thus be calculated that only 2 .5 of the intracellular glucosylceramide fraction (which amounts to 91 .3%) can at most have been derived from degradation and resynthesis. These considerations imply, therefore, that the fate of the original and intact C6-NBDglucosylceramide is monitored, as it is transported from the plasma membrane to the Golgi complex . It thus follows that C6-NBD-glucosylceramide and C6-NBD-sphingomyelin are actively sorted in HT29 cells during endocytic uptake . Whether early endosomes play a pivotal role in this lipid
The Joumal of Cell Biology, Volume 114, 1991 sorting event-analogous to events in ligand/receptor trafficking-remains to be established . In this context it is interesting to note, however, that the sorting process as such seems to be rather specific. This became apparent when the trafficking of C6-NBD-glucosylceramide was compared to that of the closely related sphingolipids C6 -NBD-galactosylceramide and C6-NBD-lactosylceramide, both of which can be synthesized by the HT29 cells (see above) . Of these three glycolipids, only C6-NBD-glucosylceramide is transported to the Golgi apparatus . Both C6-NBD-galactosylceramide and C6-NBD-lactosylceramide, similarly as observed for C6-NBD-sphingomyelin, were processed along the endosomal/lysosomal route (Fig . 1) .
Interestingly, when the trafficking of C6-NBD-glucosylceramide and C6-NBD-sphingomyelin, occurring in undifferentiated HT29 cells, was compared to that in a differentiated type of HT29 cells (isolated by clonal selection ; Babia, T., J . W Kok, and D. Hoekstra, manuscript in preparation), sorting between the lipids no longer occurred . As shown in Fig . 4 , in differentiated cells both C6-NBD-sphingolipids followed the endocytic pathway during internalization and Figure 4 . Intracellular localization of sphingolipids in differentiated HT29 cells. Cells were labeled with 4 uM C6-NBD-glucosylceramide (a, e, and i) or C6-NBD-sphingomyelin (c and g), as described in Materials and Methods. Internalization was allowed to proceed for 30 min at 37°C, followed by a back-exchange procedure at 2°C. Colabeling studies were performed with LRTf (b and d), LR-ricin (f and h), or DECA-ceramide (j), as described in Materials and Methods. Both C6-NBD-glucosylceramide and C6-NBD-sphingomyelin colocalize with both LRTf and LR-ricin . Note that C6-NBD-glucosylceramide does not colocalize with DECA-ceramide (i and j), as opposed to their colocalization in undifferentiated HT29 cells (Fig . 1, a and b) . Bar, 10 pm . perfectly colocalized with rhodamine-labeled Tf, a well-known marker for receptor-mediated endocytosis (15) . Colocalization was also observed in double-labeling studies with LRricin as the endocytic marker. In this case, however, both sphingolipids and ricin were often found to colocalize in bright juxtanuclear patches of fluorescence (Fig . 4) . This typical distribution pattern of endocytic vesicles may have been induced by the ricin, since no such patches were observed in double-labeling studies with Tf. In contrast to its localization in undifferentiated HT29 cells ( Fig. 1 ; see above) , C6 -NBD-glucosylceramide does not colocalize with DECAceramide in this cell type, because the lipid is not transported to the Golgi apparatus (Fig. 4) .
In summary, the results show that two C6 -NBDsphingolipids, glucosylceramide and sphingomyelin, are actively sorted during endocytosis in undifferentiated HT29 cells . This sorting process is lipid specific, since out of several glycolipids only C6-NBD-glucosylceramide is sorted from C6-NBD-sphingomyelin . Furthermore, this phenomenon appears to be related to the state of differentiation of the cells, being a property of the undifferentiated cells only.
